Patent Reporting. Within sixty (60) days after each Calendar Year, APBI Holdings shall provide Lilly with a written report describing the status of all Licensed Patents, including the patent country, patent and application numbers, filing date, issue date, expiration date, and any other relevant information requested by Lilly. Such report shall be mailed to ▇▇▇ ▇▇▇▇▇ and Company, Lilly Royalty Administration in Finance, ▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇, ▇▇▇▇▇ with a copy to the General Patent Counsel.
Appears in 3 contracts
Sources: Termination and License Agreement, Termination and License Agreement (Furiex Pharmaceuticals, Inc.), Termination and License Agreement (Pharmaceutical Product Development Inc)